Efficacy of peptide nucleic acid and selected conjugates against specific cellular pathologies of amyotrophic lateral sclerosis

Elisse C. Browne, Sonam Parakh, Luke F. Duncan, Steven J. Langford, Julie D. Atkin, Belinda M. Abbott*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)

    Abstract

    Cellular studies have been undertaken on a nonamer peptide nucleic acid (PNA) sequence, which binds to mRNA encoding superoxide dismutase 1, and a series of peptide nucleic acids conjugated to synthetic lipophilic vitamin analogs including a recently prepared menadione (vitamin K) analog. Reduction of both mutant superoxide dismutase 1 inclusion formation and endoplasmic reticulum stress, two of the key cellular pathological hallmarks in amyotrophic lateral sclerosis, by two of the prepared PNA oligomers is reported for the first time.

    Original languageEnglish
    Pages (from-to)1520-1527
    Number of pages8
    JournalBioorganic and Medicinal Chemistry
    Volume24
    Issue number7
    DOIs
    Publication statusPublished - 1 Apr 2016

    Keywords

    • Peptide nucleic acid
    • Amyotrophic lateral sclerosis
    • Vitamin conjugation

    Fingerprint

    Dive into the research topics of 'Efficacy of peptide nucleic acid and selected conjugates against specific cellular pathologies of amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

    Cite this